Epidemiology, Microbiological and Clinical Features, Treatment, and Outcomes of Infective Endocarditis in Crete, Greece

다국어 초록 (Multilingual Abstract)

Background: This study aimed to evaluate the epidemiology, clinical and microbiological features, treatment, and outcomes of infective endocarditis (IE) on the island of Crete, a region with high levels of antimicrobial resistance. Materials and Methods: Medical records of all hospitalized patients diagnosed with IE at the University Hospital of Heraklion, Crete, Greece, from 1995 to 2015, were retrospectively reviewed. Patients who met the modified Duke’s criteria for definite or possible IE were included. Results: A total of 82 IE patients (median age 67 [range 21–86] years) were included. Most patients suffered from left-sided IE (94%), while most cases of infection occurred in native valves (53.6%). Systemic inflammatory response syndrome criteria were lacking in almost half of the patient population. The leading causative microorganism was Staphylococcus aureus, isolated in 24 cases (29%), followed by Streptococcus spp. in 15 (18%) and Enterococcus spp. in 12 (14.5%). A number of rare and difficult to treat microorganisms had been identified, such as Gemella morbillorum in four cases (4.5%), Streptococcus lugdunensis in two (2.5%) and Streptococcus pneumoniae in one (1%). One patient was serologically positive for Coxiella burnetii (1%). All patients received empirical antimicrobial treatment, proven appropriate in 39 blood culture-positive patients (56.5%). Thirteen (16%) patients were classified as culture negative. Seven patients (8.5%) were surgically treated. In-hospital death occurred in 9 patients (11%). Conclusion: Changes in IE profile requires continuous epidemiological updates. Staphylococcus and Streptococcus spp. remain the most common etiologic agents. However, the presence of uncommon and/or difficult to treat pathogens raise concerns on the appropriate prophylaxis as well as empirical treatment.

참고문헌 (Reference)

1 Toyoda N, "Trends in infective endocarditis in California and New York State, 1998-2013" 317 : 1652-1660, 2017

2 Darouiche RO, "Treatment of infections associated with surgical implants" 350 : 1422-1429, 2004

3 Erichsen P, "The increasing incidence of infective endocarditis in Denmark, 1994-2011" 35 : 95-99, 2016

4 Zhu W, "The changing epidemiology and clinical features of infective endocarditis: a retrospective study of 196 episodes in a teaching hospital in China" 17 : 113-, 2017

5 Kanafani ZA, "Revisiting the effect of referral bias on the clinical spectrum of infective endocarditis in adults" 29 : 1203-1210, 2010

6 Kokkini S, "Q fever endocarditis in Greece: report of five cases" 15 (15): 136-137, 2009

7 Li JS, "Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis" 30 : 633-638, 2000

8 Cockcroft DW, "Prediction of creatinine clearance from serum creatinine" 16 : 31-41, 1976

9 Giannitsioti E, "Nosocomial vs. community-acquired infective endocarditis in Greece: changing epidemiological profile and mortality risk" 13 : 763-769, 2007

10 Loupa C, "Infective endocarditis in Greece: a changing profile. Epidemiological, microbiological and therapeutic data" 10 : 556-561, 2004

11 Moreillon P, "Infective endocarditis" 363 : 139-149, 2004

12 Cabell CH, "Increasing rates of cardiac device infections among Medicare beneficiaries: 1990-1999" 147 : 582-586, 2004

13 Paul M, "Importance of appropriate empirical antibiotic therapy for methicillin- resistant Staphylococcus aureus bacteraemia" 65 : 2658-2665, 2010

14 Ambrosioni J, "Hospital clinic infective endocar ditis investigators. The changing epidemiology of infective endocarditis in the Twenty-First Century" 19 : 21-, 2017

15 Bin Abdulhak AA, "Global and regional burden of infective endocarditis, 1990-2010: a systematic review of the literature" 9 : 131-143, 2014

16 Stevens PE, "Evaluation and management of chronic kidney disease: synopsis of the kidney disease: improving global outcomes 2012 clinical practice guideline" 158 : 825-830, 2013

17 Cresti A, "Epidemiological and mortality trends in infective endocarditis, a 17-year population-based prospective study" 7 : 27-35, 2017

18 Kofteridis DP, "Endocarditis caused by Gemella morbillorum resistant to beta-lactams and aminoglycosides" 38 : 1125-1127, 2006

19 Durante-Mangoni E, "Current features of infective endocarditis in elderly patients: results of the International Collaboration on Endocarditis Prospective Cohort Study" 168 : 2095-2103, 2008

20 Munoz P, "Current epidemiology and outcome of infective endocarditis: a multicenter, prospective, cohort study" 94 : e1816-, 2015

21 Murdoch DR, "Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century: the International Collaboration on Endocarditis-Prospective Cohort Study" 169 : 463-473, 2009

22 Xu H, "Characteristics of infective endocarditis in a tertiary hospital in East China" 11 : e0166764-, 2016

23 European Centre for Disease Prevention, "Antimicrobial resistance surveillance in Europe 2015: annual report of the European antimicrobial resistance surveillance network (EARS-Net)" ECDC 2017

24 Tleyjeh IM, "A systematic review of population-based studies of infective endocarditis" 132 : 1025-1035, 2007

25 Habib G, "2015 ESC Guidelines for the management of infective endocarditis: The Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by: European Association for Cardio- Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM)" 36 : 3075-3128, 2015